Steve Artale

Steve Artale is currently serving as the Asset Project Manager at Pfizer, focusing on the company's lead nonalcoholic steatohepatitis (NASH) medicine. Since joining Pfizer in 2010, they have taken on various roles, including Portfolio & Decision Analysis and Business Development Cost Lead, where they led valuation efforts and developed cost analysis processes. Artale holds a Master’s degree in Business Administration from the University of Rhode Island and a Bachelor’s degree in English from the University of Connecticut. In addition to their work at Pfizer, they also serve as a Technical Consultant for Court Square Group.